Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic diversity and medicinal drug response in eye care.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie - 1 Aug 2010

Shastry Barkur S

Abstract excerpt

BACKGROUND: Individual variation in drug response and adverse drug reactions are a serious problem in medicine. This inter-individual variation in drug response could be due to multiple factors such as disease determinants, environmental and genetic factors. Much has been published in the literature in recent years about the potential of pharmacogenetic testing and individualized medicine. The development of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Eye Diseases
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Glaucoma

Share to Macular Degeneration

Share to Pharmaceutical Preparations

Share to Pharmacogenetics

Share to Precision Medicine

Source

Identifiers

PMID: 20204657
DOI: 10.1007/s00417-010-1333-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic diversity and medicinal drug response in eye care.PMID 20204657Read ↗

Pharmacogenomics in ophthalmology.Semantic proximity Read ↗

Genetic diversity and new therapeutic concepts.Semantic proximity Read ↗

Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis.Semantic proximity Read ↗

MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension.Semantic proximity Read ↗

Should We Test for Genotype in Deciding on Age-Related Eye Disease Study Supplementation?Semantic proximity Read ↗

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients.Semantic proximity Read ↗

The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.Semantic proximity Read ↗

Genetic susceptibility to hydroxychloroquine retinal toxicity.Semantic proximity Read ↗

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucomaSemantic proximity Read ↗

Pharmacogenetics of disease-modifying anti-rheumatic drugs.Semantic proximity Read ↗

Deducing the pathogenic contribution of recessive ABCA4 alleles in an outbred population.Semantic proximity Read ↗

Roles of CYP2C19 Gene Polymorphisms in Susceptibility to POAG and Individual Differences in Drug Treatment Response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.